# MK0767 Glipizide Comparator Cardiac Safety Study (0767-018)

> **NCT00543010** · PHASE3 · TERMINATED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 247 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** MK0767

## Key facts

- **NCT ID:** NCT00543010
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-11
- **Primary completion:** 2003-11
- **Final completion:** 2003-11
- **Target enrollment:** 247 (ACTUAL)
- **Last updated:** 2015-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00543010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00543010, "MK0767 Glipizide Comparator Cardiac Safety Study (0767-018)". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00543010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*